The US pharmaceutical industry faces several challenges when exporting to Germany, including regulatory compliance, market access barriers, and logistical issues. These challenges can be further exacerbated by overdue accounts, leading to financial losses, reputation damage, and legal implications. In order to address these issues, it is important to implement strategies…